Ebola surmaa Ugandassa. Ebola-virustieteen vaihe.

http://www.who.int/csr/don/2012_07_29/en/index.html
Otan PubMed uutisista  viimeiset 20  Ebolavirusta koskevaa tieteellistä artikkelia, joista havaitsee missä vaiheessa Ebolavirustiede on.
HAKUSANA Ebola virus  . 1452 vastausta

Results: 1 to 20 of 1452

1.

Inclusion bodies are a site of Ebola virus replication.

Hoenen T, Shabman RS, Groseth A, Herwig A, Weber M, Schudt G, Dolnik O, Basler CF, Becker S, Feldmann H.

J Virol. 2012 Aug 22. [Epub ahead of print]

PMID:

22915810

[PubMed - as supplied by publisher]

Related citations

2.

Cutaneous manifestations of filovirus infections.

Nkoghe D, Leroy EM, Toung-Mve M, Gonzalez JP.

Int J Dermatol. 2012 Sep;51(9):1037-43. doi: 10.1111/j.1365-4632.2011.05379.x.

PMID:

22909355

[PubMed - in process]

Related citations

3.

Monoclonal Antibody 3D12 Anti-Ebola Virus NP.

[No authors listed]

Hybridoma (Larchmt). 2012 Aug;31(4):296. No abstract available.

PMID:

22894786

[PubMed - in process]

Related citations

4.

A replication-deficient rabies virus vaccine expressing Ebola virus glycoprotein is highly attenuated for neurovirulence.

Papaneri AB, Wirblich C, Cann JA, Cooper K, Jahrling PB, Schnell MJ, Blaney JE.

Virology. 2012 Aug 10. [Epub ahead of print]

PMID:

22889613

[PubMed - as supplied by publisher]

Related citations

5.

Further characterization of the immune response in mice to inactivated and live rabies vaccines expressing Ebola virus glycoprotein.

Papaneri AB, Christophwirblich, Cooper K, Jahrling PB, Schnell MJ, Blaney JE.

Vaccine. 2012 Aug 8. [Epub ahead of print]

PMID:

22884661

[PubMed - as supplied by publisher]

Related citations

6.

The ebola virus glycoprotein contributes to but is not sufficient for virulence in vivo.

Groseth A, Marzi A, Hoenen T, Herwig A, Gardner D, Becker S, Ebihara H, Feldmann H.

PLoS Pathog. 2012 Aug;8(8):e1002847. Epub 2012 Aug 2.

PMID:

22876185

[PubMed - in process]

Free PMC Article

Related citations

7.

Therapeutics for filovirus infection: traditional approaches and progress towards in silico drug design.

Shurtleff AC, Nguyen TL, Kingery DA, Bavari S.

Expert Opin Drug Discov. 2012 Aug 8. [Epub ahead of print]

PMID:

22873527

[PubMed - as supplied by publisher]

Related citations

8.

A convenient and general expression platform for the production of secreted proteins from human cells.

Aydin H, Azimi FC, Cook JD, Lee JE.

J Vis Exp. 2012 Jul 31;(65). pii: 4041. doi: 10.3791/4041.

PMID:

22872008

[PubMed - in process]

Related citations

9.

[Development of methodology for predictably significant evaluation of the protective efficacy of antiviral agents].

Markin VA.

Vopr Virusol. 2012 Mar-Apr;57(2):14-9. Russian.

PMID:

22834141

[PubMed - indexed for MEDLINE]

Related citations

10.

Serological evidence of ebola virus infection in indonesian orangutans.

Nidom CA, Nakayama E, Nidom RV, Alamudi MY, Daulay S, Dharmayanti IN, Dachlan YP, Amin M, Igarashi M, Miyamoto H, Yoshida R, Takada A.

PLoS One. 2012;7(7):e40740. Epub 2012 Jul 18.

PMID:

22815803

[PubMed - in process]

Free PMC Article

Related citations

11.

On case-fatality rate: review and hypothesis.

Yoshikura H.

Jpn J Infect Dis. 2012 Jul;65(4):279-88.

PMID:

22814148

[PubMed - in process]

Free Article

Related citations

12.

Detection of Nipah Virus RNA in Fruit Bat (Pteropus giganteus) from India.

Yadav PD, Raut CG, Shete AM, Mishra AC, Towner JS, Nichol ST, Mourya DT.

Am J Trop Med Hyg. 2012 Jul 16. [Epub ahead of print]

PMID:

22802440

[PubMed - as supplied by publisher]

Free Article

Related citations

13.

Assembly of Ebola Virus Matrix Protein VP40 Is Regulated by Latch-Like Properties of N and C Terminal Tails.

Silva LP, Vanzile M, Bavari S, Aman JM, Schriemer DC.

PLoS One. 2012;7(7):e39978. Epub 2012 Jul 5.

PMID:

22792204

[PubMed - in process]

Free PMC Article

Related citations

14.

Microparticles and infectious diseases.

Delabranche X, Berger A, Boisramé-Helms J, Meziani F.

Med Mal Infect. 2012 Aug;42(8):335-43. Epub 2012 Jul 4.

PMID:

22766273

[PubMed - in process]

Related citations

15.

Chinese hamster ovary cell lines selected for resistance to ebolavirus glycoprotein mediated infection are defective for NPC1 expression.

Haines KM, Vande Burgt NH, Francica JR, Kaletsky RL, Bates P.

Virology. 2012 Oct 10;432(1):20-8. Epub 2012 Jun 21.

PMID:

22726751

[PubMed - in process]

Related citations

16.

Investigation of ebola VP40 assembly and oligomerization in live cells using number and brightness analysis.

Adu-Gyamfi E, Digman MA, Gratton E, Stahelin RV.

Biophys J. 2012 Jun 6;102(11):2517-25. Epub 2012 Jun 5.

PMID:

22713567

[PubMed - in process]

Related citations

17.

Ebola virus antibodies in fruit bats, Ghana, West Africa.

Hayman DT, Yu M, Crameri G, Wang LF, Suu-Ire R, Wood JL, Cunningham AA.

Emerg Infect Dis. 2012 Jul;18(7):1207-9. doi: 10.3201/eid1807.111654. No abstract available.

PMID:

22710257

[PubMed - in process]

Free PMC Article

Related citations

18.

A seroepidemiologic study of Reston ebolavirus in swine in the Philippines.

Sayama Y, Demetria C, Saito M, Azul RR, Taniguchi S, Fukushi S, Yoshikawa T, Iizuka I, Mizutani T, Kurane I, Malbas FF Jr, Lupisan S, Catbagan DP, Animas SB, Morales RG, Lopez EL, Dazo KR, Cruz MS, Olveda R, Saijo M, Oshitani H, Morikawa S.

BMC Vet Res. 2012 Jun 18;8(1):82. [Epub ahead of print]

PMID:

22709971

[PubMed - as supplied by publisher]

Free Article

Related citations

19.

Successful treatment of ebola virus-infected cynomolgus macaques with monoclonal antibodies.

Qiu X, Audet J, Wong G, Pillet S, Bello A, Cabral T, Strong JE, Plummer F, Corbett CR, Alimonti JB, Kobinger GP.

Sci Transl Med. 2012 Jun 13;4(138):138ra81.

PMID:

22700957

[PubMed - in process]

Related citations

20.

Prediction and identification of mouse cytotoxic T lymphocyte epitopes in Ebola virus glycoproteins.

Wu S, Yu T, Song X, Yi S, Hou L, Chen W.

Virol J. 2012 Jun 13;9:111.

PMID:

22695180

[PubMed - in process]

Free PMC Article

Related citations